Diagnosis and management of pancreatic cancer: A review for physicians

Pancreatic cancer is the fourth leading cause of death from cancer, and while family physicians in Canada only see 1 cases a year, the number of cases is expected to increase as the population ages. A review in CMAJ (Canadian Medical Association Journal) provides an evidence-based overview of diagnosis and treatment of the disease for general physicians.

The main risk factor for pancreatic cancer is smoking, although about 20% of patients have a family history of the disease. Symptoms usually manifest 10 years after the start of the disease, which means screening has theoretical benefits although there are no evidence-based standardized screening protocols. For people with hereditary pancreatic cancer, screening on a limited investigational protocol begins 10 years before the youngest relative was diagnosed or at age 40, whichever comes first. Diagnostic tests include abdominal ultrasounds and CT scans, the latter being used to diagnose the stage of cancer and the location of the position of the tumour in relation to vessels and other organs.

Surgery can be successful for cancers that have not spread beyond the pancreas, with a 5-year survival of 15%, but higher in some cases (25

More information: www.cmaj.ca/lookup/doi/10.1503/cmaj.111697

add to favorites email to friend print save as pdf

Related Stories

Gene identified in increasing pancreatic cancer risk

Dec 29, 2011

Mutations in the ATM gene may increase the hereditary risk for pancreatic cancer, according to data published in Cancer Discovery, the newest journal of the American Association for Cancer Research.

Recommended for you

How a common antacid could lead to cheaper anti-cancer drugs

2 hours ago

A popular indigestion medication can increase survival in colorectal cancer, according to research published in ecancermedicalscience. But in fact, scientists have studied this for years - and a group of cancer advocates want t ...

Vaccines may make war on cancer personal

2 hours ago

In the near future, physicians may treat some cancer patients with personalized vaccines that spur their immune systems to attack malignant tumors. New research led by scientists at Washington University ...

Funding to investigate an alternative to chemotherapy

3 hours ago

Professor Simon Rule, Professor in Haematology at Plymouth University Peninsula Schools of Medicine and Dentistry and Consultant Haematologist at Plymouth Hospitals NHS Trust, has been awarded a significant grant by Cancer ...

Enzyme may be key to cancer progression in many tumors

3 hours ago

Mutations in the KRAS gene have long been known to cause cancer, and about one third of solid tumors have KRAS mutations or mutations in the KRAS pathway. KRAS promotes cancer formation not only by driving ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.